Concepedia

Author

José Baselga

Memorial Sloan Kettering Cancer CenterORCID

Also Known As

Baselga Jose, Baselga José, Baselga, José, Baselga,Jose, H. Eidtmann, Ian Smith, J Baselga, J M Baselga, J. Baselga, J. M. Baselga

1.4K

Publications

116.6K

Citations

143

H-Index

193

Concepts

All Affiliations

Memorial Sloan Kettering Cancer CenterVall d'Hebron Hospital UniversitariMassachusetts General HospitalDana-Farber Cancer InstituteVall d'Hebron Institute of Oncology
JB

About

José Baselga is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

75

219

44.1K

2

Health Sciences

30

50

9.6K

3

Engineering

6

6

3K

4

Natural Sciences

2

2

103

5

Law

1

1

24

José Baselga

×

377

Publications

104.4K

Citations

136

H-Index

YearCitations

Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer

Martine Piccart, Marion Procter, Brian Leyland‐Jones,

New England Journal of Medicine

2005

5.1K

Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

James A. Bonner, Paul M. Harari, J. Giralt,

New England Journal of Medicine

2006

5.1K

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

Robert Samstein, Chung‐Han Lee, Alexander N. Shoushtari,

Nature Genetics

2019

4.2K

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

Ahmet Zehir, Ryma Benayed, Ronak Shah,

Nature Medicine

2017

3.4K

Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer

José Baselga, Mario Campone, Martine Piccart,

New England Journal of Medicine

2011

2.8K

OncoKB: A Precision Oncology Knowledge Base

Debyani Chakravarty, Jianjiong Gao, Sarah Phillips,

JCO Precision Oncology

2017

2.6K

mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt

Kathryn O’Reilly, F. Rojo, Qing‐Bai She,

Cancer Research

2006

2.5K

Systematic identification of genomic markers of drug sensitivity in cancer cells

Mathew J. Garnett, Elena J. Edelman, Sonja J. Heidorn,

Nature

2012

2.5K

Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition

Min Yu, Aditya Bardia, Ben S. Wittner,

Science

2013

2.4K

Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer

Sandra M. Swain, José Baselga, Sung‐Bae Kim,

New England Journal of Medicine

2015

2.1K

Page 1